Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Blood | 3 | 2014 | 47 | 0.590 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2014 | 76 | 0.550 |
Why?
|
| Sulfides | 2 | 2024 | 58 | 0.440 |
Why?
|
| Allyl Compounds | 2 | 2024 | 47 | 0.440 |
Why?
|
| Monocytes | 1 | 2014 | 258 | 0.410 |
Why?
|
| Garlic | 1 | 2024 | 31 | 0.240 |
Why?
|
| Precancerous Conditions | 1 | 2024 | 81 | 0.230 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 416 | 0.220 |
Why?
|
| Cystatins | 3 | 2007 | 17 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 245 | 0.200 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2021 | 34 | 0.200 |
Why?
|
| Breast | 1 | 2021 | 134 | 0.190 |
Why?
|
| Cathepsin D | 3 | 2007 | 15 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2021 | 366 | 0.160 |
Why?
|
| Lysosomes | 3 | 2007 | 80 | 0.160 |
Why?
|
| Antigens, CD19 | 2 | 2014 | 13 | 0.150 |
Why?
|
| Oxidopamine | 2 | 2006 | 18 | 0.150 |
Why?
|
| Rats | 6 | 2014 | 3261 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 43 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2014 | 1534 | 0.120 |
Why?
|
| Antigens, CD | 1 | 2014 | 116 | 0.120 |
Why?
|
| Glycoproteins | 1 | 2014 | 100 | 0.120 |
Why?
|
| Oxidative Stress | 4 | 2024 | 874 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 181 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 1426 | 0.110 |
Why?
|
| Cathepsin B | 3 | 2007 | 29 | 0.110 |
Why?
|
| Caspase 3 | 3 | 2007 | 194 | 0.110 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 341 | 0.100 |
Why?
|
| Peptides | 1 | 2014 | 308 | 0.100 |
Why?
|
| Sympatholytics | 2 | 2006 | 13 | 0.090 |
Why?
|
| Receptors, Adrenergic | 1 | 2009 | 11 | 0.090 |
Why?
|
| Cell Communication | 1 | 2010 | 93 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2023 | 1149 | 0.090 |
Why?
|
| Spleen | 1 | 2009 | 192 | 0.080 |
Why?
|
| Microglia | 1 | 2010 | 152 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 57 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 181 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 33 | 0.070 |
Why?
|
| Animals | 6 | 2014 | 14307 | 0.070 |
Why?
|
| Humans | 7 | 2024 | 34853 | 0.070 |
Why?
|
| Cystatin C | 3 | 2007 | 21 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 139 | 0.060 |
Why?
|
| PC12 Cells | 3 | 2007 | 84 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 3 | 2007 | 72 | 0.050 |
Why?
|
| DNA Polymerase beta | 1 | 2021 | 13 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2021 | 22 | 0.050 |
Why?
|
| DNA Damage | 1 | 2024 | 341 | 0.050 |
Why?
|
| Antioxidants | 1 | 2024 | 386 | 0.050 |
Why?
|
| Cell Survival | 3 | 2010 | 818 | 0.050 |
Why?
|
| Benzo(a)pyrene | 1 | 2021 | 122 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2021 | 309 | 0.050 |
Why?
|
| Apoptosis | 2 | 2023 | 1317 | 0.040 |
Why?
|
| Neurons | 1 | 2006 | 1130 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2010 | 392 | 0.040 |
Why?
|
| Male | 2 | 2014 | 18870 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 2128 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2007 | 59 | 0.040 |
Why?
|
| Cytokines | 2 | 2010 | 569 | 0.030 |
Why?
|
| Cell Death | 2 | 2006 | 260 | 0.030 |
Why?
|
| Female | 2 | 2024 | 19873 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 55 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 96 | 0.020 |
Why?
|
| Fetus | 1 | 2010 | 103 | 0.020 |
Why?
|
| Adrenergic Antagonists | 1 | 2009 | 1 | 0.020 |
Why?
|
| Propanolamines | 1 | 2009 | 12 | 0.020 |
Why?
|
| Propranolol | 1 | 2009 | 17 | 0.020 |
Why?
|
| Denervation | 1 | 2009 | 26 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 29 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 50 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2009 | 72 | 0.020 |
Why?
|
| Carbazoles | 1 | 2009 | 43 | 0.020 |
Why?
|
| Glucose | 1 | 2010 | 217 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 445 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2007 | 21 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2006 | 19 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 45 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1442 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 126 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 423 | 0.020 |
Why?
|
| Caspases | 1 | 2006 | 132 | 0.020 |
Why?
|
| Dopamine | 1 | 2006 | 232 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2006 | 167 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 396 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 420 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 231 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 1300 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 834 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 859 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 549 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 1268 | 0.010 |
Why?
|